Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single caseViviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario SantinamiSee the full list of authors
4 January 2024
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockadeJulie Stein Deutsch, Jonathan Lai, Kara M Schenk, Abha Soni, Elizabeth M Will, Logan L Engle, Haiying Xu, Alexandra Ogurtsova, Vrinda Madan, Jennifer K Chong, Daphne Wang, Benjamin F Green, Peter Nguyen, Megan D Schollenberger, Evan J LipsonSee the full list of authors
14 December 2023
Complete response to immunotherapy in a patient with high-risk stage III colorectal cancer after ctDNA-guided detection of early adjuvant treatment failureNicholas Lucchesi, Jenna M Ally, Matthew J Reilley
15 September 2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphomaSharmila Raghunandan, Melinda Pauly, William G Blum, Muna Qayed, Madhav V Dhodapkar, Mohamed Elkhalifa, Benjamin Watkins, Michelle Schoettler, Edwin Horwitz, Suhag Parikh, Shanmuganathan Chandrakasan, Kathryn Leung, Elyse Bryson, Laura Deeb, Jonathan L KaufmanSee the full list of authors
3 May 2023
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case reportChristian Koch, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Patrick Roth, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp
23 January 2023
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancerJulia Karbach, Dragan Kiselicki, Kathrin Brand, Claudia Wahle, Evgueni Sinelnikov, Dirk Gustavus, Hans Hoffmeister, Hans-Bernd Prisack, Akin Atmaca, Elke Jäger
10 January 2023
Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumabRaanan Berger, Gal Dinstag, Omer Tirosh, Eyal Schiff, David Kleiner, Kenneth D Aldape, Eytan Ruppin, Tuvik Beker, Razelle Kurzrock
9 December 2022
Dasatinib for treatment of CAR T-cell therapy-related complicationsKatharina Baur, Dominik Heim, Astrid Beerlage, Anna S Poerings, Bastian Kopp, Michael Medinger, Jan C Dirks, Jakob R Passweg, Andreas Holbro
1 December 2022
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravisWen Gao, Lingxiang Wu, Shidai Jin, Jun Li, Xinyin Liu, Jiali Xu, Wei Zhang, Qixing Gong, Chunxiao Sun, Wei Wang, Zidun Wang, Yang W Shao, Jiani C Yin, Lu Shen, Liang ChenSee the full list of authors
30 November 2022
Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatmentSong Y Park, Austin R Green, Rouba Hadi, Coley Doolittle-Amieva, Jennifer Gardner, Ata S Moshiri
28 October 2022
